of a wide range of products which include trastuzumab emtansine ujvira 100mg and bevacizumab 400 mg injection.
₹ 39995 / Vial Get Latest Price
| Strength | 100 MG |
| Packaging Type | Vial |
| Brand Name | UJVIRA |
| Manufactured By | ZYDUS |
| Usage | Clinical |
| Shelf Life | 36 MONTHS |
| COMPOSITION | TRASTUZUMAB-100MG |
Ujvira 100 mg Injection is an anti-cancer medicine used in the treatment of HER2-positive Breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Ujvira 100 mg Injection contains Trastuzumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.
₹ 39600 / Vial Get Latest Price
| Strength | 400 mg/16 ml |
| Packaging Type | Vial |
| COMPOSITION | Bevacizumab (400mg) |
| MANUFACTURED BY | Intas Pharmaceuticals Ltd |
| STORAGE | Store in a refrigerator (2 - 8°C). Do not freeze. |
Himanshu Shahu (CEO)
Medezy Healthcare And Medical Devices
House No 1920a, Besides Neha Pustkalay, Near Sakkardara Chowk,Sakkardara,Nagpur, AR Healthcare
Nagpur - 440009, Maharashtra, India